JOHNSON INVESTMENT COUNSEL INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$162,064
-5.9%
10,476
-4.4%
0.00%0.0%
Q2 2023$172,197
-5.3%
10,961
-0.6%
0.00%0.0%
Q1 2023$181,741
+3.3%
11,028
-2.2%
0.00%0.0%
Q4 2022$175,952
+18.9%
11,279
-0.9%
0.00%0.0%
Q3 2022$148,000
-6.3%
11,380
+0.9%
0.00%0.0%
Q2 2022$158,000
+7.5%
11,279
+9.8%
0.00%0.0%
Q1 2022$147,000
+1.4%
10,273
-3.7%
0.00%0.0%
Q4 2021$145,000
-39.3%
10,673
-26.9%
0.00%
-33.3%
Q3 2021$239,000
-10.2%
14,600
-5.3%
0.00%
-25.0%
Q2 2021$266,000
-7.6%
15,419
-2.4%
0.00%0.0%
Q1 2021$288,000
-3.0%
15,797
-3.2%
0.00%
-20.0%
Q4 2020$297,000
+1.7%
16,314
-0.5%
0.01%0.0%
Q3 2020$292,000
-3.9%
16,389
-1.2%
0.01%
-16.7%
Q2 2020$304,000
+21.1%
16,585
+0.5%
0.01%0.0%
Q1 2020$251,000
-23.0%
16,5050.0%0.01%0.0%
Q4 2019$326,000
+16.4%
16,505
+1.2%
0.01%0.0%
Q3 2019$280,00016,3050.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders